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Abstract—An anodic aluminon oxide (AAO)-based nano 
honeycomb electrode was fabricated on a quartz crystal to 
increase the surface area binding with analyte for use as a sensing 
device in a quartz crystal microbalance (QCM) to monitor the 
protein-protein interactions (PPIs). As examples, we detected 
PPIs of anti-Bcl-2 and Bcl-2, and Bcl-2 and Bax in real time. A 
sensor with a flat Au electrode showed a tiny frequency shift upon 
sample injection. However, our fabricated device could detect 
Bcl-2 and Bax in sequence. Frequency shifts corresponding to the 
binding of Bcl-2 to anti Bcl-2, and that of Bax to Bcl-2 increased 
linearly. 
 
Index Terms—Biosensor, quartz crystal microbalance (QCM), 
protein-protein interaction, real time detecting.  
 
I. INTRODUCTION 
rotein-protein interactions (PPIs) play key roles in a variety 
of biological processes such as intercellular and 
intracellular signal transduction [1, 2]. Although dysregulated 
PPIs are potent targets in drug discovery, there is a limited 
number of potential PPI inhibitors [3, 4]. For example, many 
monoclonal antibodies (mAbs) are therapeutic drugs that act 
via the inhibition of intercellular PPIs. However, mAbs are not 
appropriate for disrupting intracellular PPIs because of their 
poor cell permeability, therefore the application of these drugs 
is limited [5, 6]. To overcome this hurdle, the discovery of 
low-molecular-weight compounds that inhibit intracellular 
PPIs has attracted the interest of medicinal chemists [4, 7]. 
To evaluate PPIs, the binding and dissociation of compounds 
to the target protein and the combined multiplier are measured 
using conventional techniques such as enzyme-linked 
immunosorbent assay (ELISA) [8-10]. ELISA can be used to 
analyze a large number of samples; however, it requires 
professional skills and takes a long time because of the need for 
labeling and incubation. In addition, ELISA is not suitable for 
real-time monitoring. On the other hand, surface plasmon 
resonance (SPR) [11-13] and quartz crystal microbalance 
(QCM) methods [14-16] are concise, cost-effective, and 
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powerful methodologies for monitoring real-time PPIs. Since 
these techniques are performed using flow injection methods, 
pharmaceutical researchers use them for high-throughput 
screening. Since SPR systems involve complicated optical 
systems such as a goniometer, they are generally quite large. In 
contrast, a QCM is simple, convenient, cost-effective, and 
small owing to the use of common electronic device 
technologies coupled with a microfluidic device. A QCM 
includes an AT-cut quartz crystal, whose fundamental resonant 
frequency is mainly determined by the thickness of the quartz 
crystal. When the target material is attached on the electrode 
surface of the quartz crystal, the resonant frequency decreases 
and the magnitude of the frequency shift is proportional to the 
change in mass. Therefore, the development of a 
high-sensitivity electrode for PPIs is necessary for the effective 
screening of intracellular PPI inhibitors. Here we describe a 
high-sensitivity electrode with a nano-honeycomb structure and 
its application detection of PPIs between anti B-cell lymphoma 
(Bcl)-2 and Bcl-2 and between Bcl-2 and Bcl-2-associated X 
protein (Bax). 
In our program to develop novel methodology to detect PPI 
inhibitors, we have focused on the interaction between Bcl-2 
and Bax. Inhibiting this interaction will lead to the apoptosis of 
cancer cells. Members of the Bcl-2 family of proteins are 
essential in regulating apoptosis [17]. The effects of Bcl-2, 
Bcl-extra large (xL), and Bax (molecular weight: 36.74 kDa) on 
the regulation of the apoptosis of mesangial cells have been 
investigated by many groups [18-20]. When Bax directly binds 
to the pocket of Bcl-2 (molecular weight: 36.63 kDa), apoptosis 
is suppressed. Therefore, Bcl-2 inhibitors are potent candidates 
for the treatment of cancer. Most research groups have used 
ELISA and western blot analysis to detect Bcl-2-related 
interactions [21-23] and a few groups have attempted to use 
SPR [24]. However, no group has ever shown the possibility of 
using a QCM to measure the interaction of Bcl-2 and Bax.  
To improve the sensitivity of a QCM, three approaches have 
been followed: (1) using very thin quartz crystal, (2) using 
nanoparticles to increase the weight and (3) increasing the 
surface area to enable the attachment of a larger quantity of the 
target materials. Using the first strategy, the fundamental 
frequency was increased to 150 MHz by fabricating extremely 
thin quartz (thickness: 25 µm) without an electrode or wiring to 
apply an AC voltage [25]. In this case, the quartz was too thin 
for it to be used in practical applications. In addition, the 
proposed QCM-based sensor required a special AC source. On 
Nano-honeycomb electrode based QCM sensor 
and its application for PPI detection 
Naoto Asai, Naohiro Matsumoto, Nozomi Kazama, Yasuo Nagaoka, Takaaki Sumiyoshi,                    
Tomohiro Shimizu, Shoso Shingubara, Takeshi Ito* 
P 
the second strategy, gold nanoparticles and magnetic 
nanoparticles were used [26, 27]. These techniques need extra 
preparation procedure for functionalization of nanoparticles.  
Using the third strategy, nanostructures were introduced to 
increase the surface area for binding with analyte [28-30]. In 
this case, sensor preparation is easy and conventional. We have 
focused on this strategy, which was realized using a 
three-dimensional (3D) nanostructure based on anodic 
aluminum oxide (AAO). The AAO nanostructure is obtained 
by anodizing only aluminum under a suitable potential in an 
electrolyte solution with a counter electrode [31]. Then, a 
self-organized nanohole array having a triangular lattice is 
formed in the downward direction with the nanoholes having a 
high aspect ratio which we refer to as a nano-honeycomb 
structure. The aspect ratio is controllable via the anodic 
conditions, such as the electrolyte solution, applied voltage, 
anodization time, and solution temperature [32]. Appropriate 
conditions result in a nanostructure with a self-assembled 
nanohole array and high aspect ratio using a conventional 
fabrication process. Therefore, an AAO nano-honeycomb 
structure having a large area can be fabricated at a low cost. 
II. EXPERIMENTAL 
A. Fabricating nano-honeycomb electrode on the quartz 
crystal 
A schematic diagram of the fabrication process for a quartz 
crystal substrate coated with a nano-honeycomb electrode is 
shown in Fig. 1. An aluminum thin film of 700 nm thickness 
and a titanium thin film of 25 nm thickness were sputtered on a 
quartz substrate (fundamental frequency: 9 MHz) using DC 
magnetron sputtering equipment. The Ti film was used as an 
adhesion layer. The diameter of the electrode was set to 5 mm. 
All the reagents used to fabricate the AAO nanostructure and 
form the self-assembled monolayer (SAM) were purchased 
from Wako Pure Chemical Industries. The AAO nanostructure 
was obtained by anodization of the Al thin film in 0.3 M oxalic 
acid. A potential of 40 V was applied between the Al thin film 
and a glassy carbon counter electrode. These anodic conditions 
are suitable for the formation of a self-assembled nanohole 
array [33]. After the anodization, the nanohole diameter was 
increased to 70 nm by dipped in 5 wt% phosphoric acid. The 
nanostructure was fabricated on one side of the quartz substrate. 
The other side was coated with indium tin oxide (ITO) of 25 nm 
thickness and Au of 100 nm thickness by sputtering. Stop-view 
Fig.1 Upper: SEM images corresponding to process steps (1)-(3). Lower: Schematic figure of process used to fabricate nano-honeycomb electrode on quartz 
crystal. 
Fig.2 Cross-section SEM image of fabricated AAO-based 
nano-honeycomb layer on the quartz substrate. 
scanning electron microscopy (SEM) images taken during the 
process are shown in Fig. 1. After the anodization (2), small 
holes with a diameter of 30 nm were distributed irregularly on 
the top surface of the Al. Although the two-step anodization of 
Al would have produced a regular array of nanoholes, the 
thickness of the Al layer was insufficient for it to be performed. 
After the etching of the nanoholes, their diameter was increased 
to about 70 nm. Fig. 2 shows a cross-section SEM image taken 
after the etching (3). The AAO nanostructure was vertically 
well aligned and uniformly distributed on the substrate. The 
thickness of the AAO nanostructure was about 700 nm 
according to the SEM image. These growth conditions of the 
AAO structure were previously optimized and reported 
elsewhere [34]. The diameter and growth direction at the top of 
the AAO nanostructure were less uniform than those at the 
bottom because the initially formed small nanoholes were 
electrolyzed and grew vertically downward along the 
roughness of the as-sputtered Al thin film [35]. 
 
B. Biomolecules immobilization 
To use the fabricated device for biosensing, some 
biomaterials were coated on the device such as antigens. An 
antigen can bind an antibody specifically. However, a 
biomolecule cannot directly attach to an AAO surface since 
AAO does not have a functional group that can immobilize 
biomolecules. Thus, we used a SAM with terminated amino 
group. The QCM sensor coated with a nano-honeycomb 
electrode was immersed in toluene including 
3-aminopropyltriethoxysilane (toluene: 
3-aminopropyltriethoxysilane = 99:1) for 1 h at 65 oC. After 
sonicating with 2-propanol, it was baked for 30 min at 110 oC to 
induce the dehydration condensation of a SAM. Then, a stable 
SAM was formed on the surface of the AAO-nanostructure. 
Anti-Bcl-2 (mAbs), Bcl-2, and bovine serum albumin (BSA) 
were purchased from Funakoshi Co., Ltd. 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 
10 mM, pH=7.6) was used as a buffer solution. 25 μL of 
anti-Bcl-2 (100 µg/mL) was added dropwise to the electrode 
for 30 min to bind it on the AAO-nanostructure. After washing 
with HEPES buffer to prevent the nonspecific adsorption of 
anti-Bcl-2, 25 μL of BSA solution (0.01 wt%) was added 
dropwise over 30 min to avoid nonspecific adsorption. Then, it 
was rinsed by the HEPES buffer again. Here, the anti-Bcl-2 and 
BSA were immobilized by amide linkages between the amino 
group on the SAM layer and the carboxyl group included in the 
biomolecules [36].  
On the contrast, QCM sensor with Au flat electrode was used 
as a benchmark. The electrode was coated by only dropping 
solution including anti-Bcl-2 (100 µg/mL) and BSA (0.01 
wt%) in order. These proteins bound on the Au electrode 
through thiol binding. 
 
C. PPI detection using flow injection analysis 
These QCM sensors were set on a measurement cell, which 
was connected to a flow injection system. The measurement 
cell had a flow cell, an inlet, and an outlet made of 
poly(dimethylsiloxane) (PDMS). The depth and diameter of the 
flow cell were 1 and 5.5 mm, respectively. The QCM-based 
sensor with the measurement cell was connected to a QCM 
analyzer (QCM 922A, Seiko EG&G) then placed in a 
constant-temperature chamber to maintain the room 
temperature. The overtone number was set to three (n=3); thus, 
the operating frequency was 27 MHz. The frequency shift was 
monitored with a flow rate of 5 µl/min, which was controlled by 
a syringe pump. We measured the frequency shift 
corresponding to the antigen-antibody reaction by injecting 
Bcl-2 firstly and different concentrations of Bax in sequence, 
which demonstrated to monitor the interaction between Bcl-2 
and Bax. All the injection volume was set as 50 µl.  
III. RESULTS AND DISCUSSION 
The resonance characteristics of the fabricated QCM chip 
during the preparation process are shown in Fig. 3. Here, 
Fig. 3(a) shows the characteristics for the QCM sensor 
coated with the nano-honeycomb electrode and Fig. 3(b) 
shows those for the QCM sensor with a flat Au electrode. 
All the measurements were carried out in air. In the case of 
the nano-honeycomb electrode, the resonance frequency 
decreased during the process, and the frequency shift after 
binding of the antibody was about 1200 Hz. In the case of 
Fig.3 Resonance characteristics of the AAO-based nano-honeycomb 
electrode (a) and flat Au electrode (b) during the preparation process. 
the flat Au electrode, the resonant frequency decreased by 
about 400 Hz after antibody binding. In fact, the frequency 
shift on the nano-honeycomb electrode was three times 
larger than that on the flat surface in the antibody-binding 
process. The result indicated that the mass load of the 
antibody increased owing to the large surface area of the 
nano-honeycomb structure. In addition, the resonant 
frequency did not change after the binding of BSA for both 
electrodes. The data indicate that there was very little 
space for the binding of BSA to the electrode surface. 
These results show that the mass load increased during the 
process because the biomolecules were accurately 
immobilized on the surface of the nano-honeycomb 
structure.  
 The interaction between an antigen (Bcl-2) and an 
antibody (anti-Bcl-2) and interaction between two proteins 
of Bcl-2 and Bax were evaluated using the QCM. In fact, 
we first carried out real-time monitoring of the frequency 
shift corresponding to the adhesion of Bcl-2 to anti-Bcl-2 
followed that for the adhesion of Bax to Bcl-2. To evaluate 
the effect of the large surface area due to the nanostructure, 
a commercially available QCM sensor with a gold 
electrode on both sides of the quartz crystal was used as a 
reference. It had a fundamental frequency of 9 MHz but a 
working frequency was set as 27 MHz. In this case, a flat 
Au electrode had a diameter of 5 mm. These conditions 
were exactly the same as those for the fabricated QCM 
device with AAO nanostructure. In this experiment, we 
injected Bcl-2 (10 µg/mL) after the resonance frequency 
reached the steady state. After measuring the interaction 
between anti-Bcl-2 and Bcl-2, Bax (10 µg/mL) was also 
injected to monitor the interaction between Bcl-2 and Bax. 
The obtained time-dependent frequency shift is shown in 
Fig. 4. Arrows in figure show the time on the sample 
injections. The resonance frequency on both electrodes 
started to decrease approximately 20 min after the Bcl-2 
injection. In the case of the flat Au electrode, after reaching 
minimum, the resonance frequency increased to almost the 
same as that before the injection. Then, there was hardly 
any frequency shift after Bax injection since Bcl-2 was not 
adsorbed on the anti-Bcl-2. In contrast, after reaching a 
minimum, the resonance frequency increased but remained 
below the initial value for the nano-honeycomb electrode, 
indicating that the QCM sensor coated with the 
nano-honeycomb electrode was able to detect the 
interaction of Bcl-2 and anti-Bcl-2. In this case, the 
frequency shift was about 36 Hz. In addition, the resonant 
frequency also started to decrease about 23 min after Bax 
injection. The frequency shift was about 37 Hz.  
Then we measured the frequency shifts dependent with 
the concentration both on anti Bcl-2 and Bcl-2 interaction, 
and Bcl-2 and Bax interaction. As an example, Fig. 5 
shows the time-dependent frequency shift after the 
injection of Bcl-2 (2 µg/mL), subsequently injection of 
different concentrations of Bax (from 0.5 to 10 µg/mL) in 
sequence. Here, arrows in the figure show the injection 
samples. As the results, we could affirm the frequency 
shift on the Bax concentration of 0.5 μg/mL. In addition, 
absolute frequency shift increased with the Bax 
concentration. Frequency shifts on the antigen-antibody 
interaction on Fig. 5 was larger than that on Fig. 4, even 
though the concentration of Bcl-2 on Fig .5 was lower than 
that on Fig. 5. The results indicate that the sensor has 
variable sensitivity. Primitive analytical curves of anti 
Bcl-2 and Bcl-2 interaction, and Bcl-2 and Bax were 
shown in supporting information as Fig. S1 and Fig. S2, 
respectively. Here, the plots were average of twice 
experiments. Frequency shifts on the binding of Bcl-2 to 
anti Bcl-2 increased linearly in the range from 0.5 to 10 
µg/mL. In similar, frequency shifts on the binding of Bax 
to Bax increased linearly in the range from 0.5 to 10 
µg/mL. A gradient of the analytical curve on the Bcl-2 and 
Bax interaction was fewer than half of that on the anti 
Bcl-2 and Bcl-2 interaction. The result is attributed to 
some reasons. One is probability of the biding. Since the 
probability of Bcl-2 binding with anti Bcl-2, and that of 
Bax binding with Bcl-2 were lower than 100 %, the 
Fig.4 Time-dependent frequency shift corresponding to Bcl-2 and Bax 
injection. Gray and black lines represent the flat Au electrode and the 
nano-honeycomb electrode, respectively. 
Fig.5 Time-dependent frequency shift after the injection of Bcl-2 (2 
µg/mL), subsequently injection of different concentrations of Bax ( 0.5, 
1.0, 5.0, 10 µg/mL) in sequence. 
amount of analyte would decrease through the course of 
the interaction order. Secondly, the result might be 
depended on the diffusion factor of materials. Our results 
certify that QCM based sensor with the nano-honeycomb 
electrode having large surface area can detect frequency 
shifts corresponding to the PPI.  
 
IV. CONCLUSION 
 We developed a novel and high-sensitivity QCM sensor 
with an AAO and honeycomb nanostructure. In addition, 
we successfully applied the electrode to assess PPIs 
between anti Bcl-2 and Bcl-2 and between Bcl-2 and Bax. 
These results indicate that the sensitivity of the QCM is 
improved using the sensor with the nano-honeycomb 
electrode because of its large surface area for binding with 
the analyte. 
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